- Mission [1]
- FDA’s strategic priorities in responding to the public health challenges of the 21st century are to advance regulatory science
and innovation; strengthen the safety and integrity of the global supply chain; strengthen compliance and enforcement activities
to support public health; expand efforts to meet the needs of special populations; advance medical countermeasures and emergency
preparedness; advance food safety and nutrition; promote public health by advancing the safety and effectiveness of medical
products; establish an effective tobacco regulation, prevention, and control program; and manage for organizational excellence
and accountability. The Oncologic Drugs Advisory Committee supports FDA's strategic priorities by reviewing and evaluating
available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the
treatment of cancer and makes appropriate recommendations to the Commissioner of Food and Drugs. This supports the development
of safe and effective new medical technologies, and advances the status of the Agency as a science-based and science-led regulatory
agency, providing global leadership in the protection of public health.
|
